Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle

Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle

Abstract Radiotherapy (RT) has been viewed as one of the most effective and extensively applied curatives in clinical cancer therapy. However, the radioresistance of tumor severely discounts the radiotherapy outcomes. Here, an innovative supramolecular radiotherapy strategy, based on the complexatio...

Full description

Bibliographic Details
Main Authors: Xiaoxue Hou, Yu‐Xuan Chang, Yu‐Xin Yue, Ze‐Han Wang, Fei Ding, Zhi‐Hao Li, Hua‐Bin Li, Yicheng Xu, Xianglei Kong, Fan Huang, Dong‐Sheng Guo, Jianfeng Liu
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Advanced Science
Subjects:
calixarene
drug delivery
radiotherapy
supramolecular chemistry
tumor hypoxia
Online Access:https://doi.org/10.1002/advs.202104349

Internet

https://doi.org/10.1002/advs.202104349

Similar Items